- Report
- May 2025
- 50 Pages
Global
From €2424EUR$2,650USD£2,063GBP
Alfaxalone is a Central Nervous System (CNS) drug used as an anesthetic and sedative. It is a synthetic steroidal compound that acts on the GABA-A receptor, producing a sedative and hypnotic effect. It is used in veterinary medicine to induce anesthesia and sedation in animals, and is also used in humans for the same purpose. Alfaxalone is administered intravenously or intramuscularly, and is metabolized in the liver. It has a rapid onset of action and a short duration of action, making it suitable for short-term procedures.
Alfaxalone is a relatively new drug, and is not widely used in humans. However, it is gaining popularity in veterinary medicine due to its rapid onset of action and short duration of action. It is also used in combination with other drugs to produce a deeper level of anesthesia.
Some companies in the Alfaxalone market include Zoetis, Merck, and Pfizer. Show Less Read more